A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced Monday.
Q&A: Can oncolytic viruses make a comeback? Experts dissect clinical failures and outline path forward
In the eight years since the FDA first approved an oncolytic virus as a cancer therapy, developers have been striving — and largely failing —
November 18, 2023